We are live on ! Find out more
RCKT icon

Rocket Pharmaceuticals
RCKT

173 hedge funds and large institutions have $315M invested in Rocket Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 61 increasing their positions, 62 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

98% more call options, than puts

Call options by funds: $2.87M | Put options by funds: $1.45M

35% more capital invested

Capital invested by funds: $233M → $315M (+$81.8M)

0.53% more ownership

Funds ownership: 88.98% → 89.52% (+0.53%)

2% less repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 62

12% less funds holding

Funds holding: 196 → 173 (-23)

44% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 50

Holders
173
Holders Change
-23
Holders Change %
-11.73%
% of All Funds
2.27%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
28
Increased
61
Reduced
62
Closed
50
Calls
$2.87M
Puts
$1.45M
Net Calls
+$1.42M
Net Calls Change
+$925K

Top Buyers

1
MAM
Monaco Asset Management
Monaco
+$7.68M
2
Citadel Advisors
Citadel Advisors
Florida
+$4.77M
3
Millennium Management
Millennium Management
New York
+$3.85M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$3.77M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$3.72M

Top Sellers

1
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
-$2.69M
2
CSS
Cubist Systematic Strategies
Connecticut
-$1.76M
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$1.68M
4
WP
Woodline Partners
California
-$1.6M
5
N
Nuveen
North Carolina
-$1.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
76
Deutsche Bank
Germany
$263K +$33K +10,487 +15%
Bank of Montreal
77
Bank of Montreal
Ontario, Canada
$249K +$8.57K +2,721 +4%
CIA
78
Concurrent Investment Advisors
Florida
$248K +$61.4K +19,490 +34%
BIG
79
Brooklyn Investment Group
New York
$236K -$68K -21,598 -19%
EGM
80
Engineers Gate Manager
New York
$233K -$607K -192,797 -73%
VCM
81
Voleon Capital Management
California
$222K +$88.2K +28,010 +70%
Wells Fargo
82
Wells Fargo
California
$220K +$37.1K +11,784 +21%
Man Group
83
Man Group
United Kingdom
$204K +$197K +62,576 New
Macquarie Group
84
Macquarie Group
Australia
$189K – – –
AI
85
Atom Investors
Texas
$174K +$168K +53,334 New
Tudor Investment Corp
86
Tudor Investment Corp
Connecticut
$163K -$208 -66 -0.1%
SG Americas Securities
87
SG Americas Securities
New York
$159K -$46.7K -14,824 -23%
MIM
88
MetLife Investment Management
New Jersey
$151K +$1.41K +446 +1%
EAM
89
Erste Asset Management
Austria
$147K – – –
AC
90
AXQ Capital
New Jersey
$137K +$132K +41,994 New
IIM
91
INTECH Investment Management
Florida
$133K -$29.2K -9,263 -19%
Stifel Financial
92
Stifel Financial
Missouri
$128K +$72K +22,850 +140%
VIA
93
Virtus Investment Advisers
Connecticut
$121K +$20.3K +6,434 +21%
Thrivent Financial for Lutherans
94
Thrivent Financial for Lutherans
Minnesota
$117K -$55.5K -17,629 -33%
AAP
95
Arax Advisory Partners
Colorado
$117K +$113K +35,855 New
Assenagon Asset Management
96
Assenagon Asset Management
Luxembourg
$117K +$113K +35,816 New
Hudson Bay Capital Management
97
Hudson Bay Capital Management
Connecticut
$113K +$23K +7,300 +27%
Mitsubishi UFJ Asset Management
98
Mitsubishi UFJ Asset Management
Japan
$113K -$5.21K -1,653 -5%
Carson Wealth (CWM LLC)
99
Carson Wealth (CWM LLC)
Nebraska
$104K +$50.4K +16,005 +101%
DTL
100
Dynamic Technology Lab
Singapore
$100K +$96.9K +30,760 New
2 3
4
5 6

RCKT Hedge Fund Activity: Q3 2025 in Review

173 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals (RCKT) for Q3 2025, worth a combined $315M — up 35% from $233M a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of RCKT and 28 opened new positions — a net loss of 22 holders — while 62 trimmed existing stakes and 61 added.

The largest buyer was Monaco Asset Management, adding an estimated $7.68M. The largest seller was Toronto Dominion Bank, exiting entirely with an estimated $2.69M sold.

  • 173 institutional investors held Rocket Pharmaceuticals (RCKT) as of Q3 2025, down from 196 in Q2 2025.
  • Funds reported $315M of Rocket Pharmaceuticals stock for Q3 2025, up 35% quarter-over-quarter.
  • 28 funds opened new Rocket Pharmaceuticals positions in Q3 2025 and 50 closed out, a net change of -22 holders.
  • The largest Rocket Pharmaceuticals buyer in Q3 2025 was Monaco Asset Management, an estimated $7.68M added.
  • The largest Rocket Pharmaceuticals seller in Q3 2025 was Toronto Dominion Bank, an estimated $2.69M sold.

Based on aggregated 13F filings for Q3 2025.